You searched for Antibody candidate - Page 56 of 69

News and Trends 19 Feb 2018

This Belgian Biotech Gives Us an Update on its Bulging Psoriasis Pipeline

…meeting. Belgian biopharma, UCB, develops medicines for people suffering from severe diseases of the immune or central nervous systems. The company is developing a number of candidates for moderate-to-severe chronic…

February 19, 2018 - 3 minutesmins - By Alex Dale

News and Trends 30 Jan 2017

‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier

Ossianix, partnered with Lundbeck, is developing shark antibodies that can help therapeutics cross the blood brain barrier. Ossianix develops shark-inspired antibody fragments, VNARs, with outstanding properties thanks to their small…

January 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Aug 2022

Emactuzumab designated as an orphan medicinal product for TGCT in Europe

SynOx Therapeutics Limited says its novel monoclonal antibody, emactuzumab, in development for the treatment of tenosynovial giant cell tumor (TGCT) and other diseases, has been designated as an orphan medicinal…

August 31, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 12 Jul 2016

Which European Biotechs made it to the Billion-Euro Club in 2016?

…time) Founded: 1992 City: Munich (Germany) Mission: MorphoSys is a biopharmaceutical company with a rich pipeline of future therapeutic antibody products and a sustainable dual therapeutic business model. Comment: It’s…

July 12, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 20 Feb 2018

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

Phase I results show promise for a new treatment for atopic dermatitis that may become a strong competitor to the market leader, Humira. Morphosys and Galapagos are developing an antibody…

February 20, 2018 - 3 minutesmins - By Alexander Burik

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

…money to fund the preclinical development of antibody drugs for unspecified autoimmune diseases. The company will also expand its drug discovery efforts to other unspecified disease areas and grow its…

October 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 9 Aug 2022

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

…issued two patents that will protect Arecor Therapeutics’ formulations of high-concentration adalimumab until 2038. The company made the announcement today (August 9). Monoclonal antibody Adalimumab, sold by AbbVie under the…

August 9, 2022 - 3 minutesmins - By Liza Laws

News and Trends 2 Dec 2016

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

…(BDCs) outperform ADCs? Bicycle Therapeutics is a company in Cambridge founded by one of the top biotech leaders in the UK’s golden triangle. Its unique technology to develop antibody-like bicyclic…

December 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Jul 2022

Boston startup bags $40M Series A to smash preclinical bottlenecks

…of the startup is a type of drugs called targeted effectors. This class, including cell engagers and antibody-drug conjugates, involves attaching a therapeutic payload onto a carrier molecule that delivers…

July 14, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Mar 2023

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

…next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and…

March 14, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 4 Sep 2024

2024: a year of breakthroughs for endometrial cancer?

…Rochester OKN-007 – Oblato, Inc ADCs: new treatments see encouraging results in clinic Another advancement in endometrial cancer research is the development of antibody drug conjugates (ADCs) that are “designed…

September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter

antibody drug conjugate adc small cancer treatment

News and Trends 14 Apr 2023

TORL BioTherapeutics launches with $158M to target cancer

…pipeline of antibody-drug conjugates (ADCs) and monoclonal antibodies (mAbs) were discovered in the laboratory of scientific co-founder Dennis Slamon, professor of medicine, and chief of the division of hematology/oncology at…

April 14, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

This Belgian Biotech Gives Us an Update on its Bulging Psoriasis Pipeline

‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier

Emactuzumab designated as an orphan medicinal product for TGCT in Europe

Which European Biotechs made it to the Billion-Euro Club in 2016?

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

Boston startup bags $40M Series A to smash preclinical bottlenecks

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

2024: a year of breakthroughs for endometrial cancer?

TORL BioTherapeutics launches with $158M to target cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!